Literature DB >> 6743514

Cutaneous malignant melanoma in West Yorkshire: II. A prospective study of recurrence and prediction of lymph nodal metastasis.

J Eastwood, T G Baker.   

Abstract

One hundred and fifty patients with cutaneous malignant melanoma, in clinical stage I at diagnosis, were studied prospectively to determine the lymph nodal metastatic pattern of the disease, and to find that combination of clinical and pathological variables best predictive of the probability of its occurrence when combined in a linear logistic regression equation based upon a model by Cox. Details of the general pattern of melanoma recurrence are included to provide a necessary background to the nodal metastatic study. Of 66 patients showing melanoma recurrence in 48 (19 males and 29 females) it took the form of lymph nodal metastasis. Of these 50% showed lymph nodal metastasis within 1.1 years of the primary operation and 90% within 3.8 years. Nineteen clinical and pathological variables were tested for association with lymph nodal metastasis, 15 of which showed a significant association and in 7 of these the association was highly significant (P less than or equal to 0.0001). All 19 variables were included in the logistic regression analysis, 6 being selected as providing the best regression 'goodness of fit' and of these 'maximum tumour thickness (Breslow' and 'sex' emerged as the dominant variables. It is concluded that the analysis described provides surgeons, oncologists, and pathologists with a practical method to assess the likelihood in an individual patient of melanoma recurrence to regional lymph nodes. This should enable surgery or other adjunctive therapeutic regimens to be selected at an early stage.

Entities:  

Mesh:

Year:  1984        PMID: 6743514      PMCID: PMC1976927          DOI: 10.1038/bjc.1984.137

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

2.  Selective regional lymphadenectomy for melanoma: a mathematical aid to clinical judgment.

Authors:  H C Polk; B S Linn
Journal:  Ann Surg       Date:  1971-09       Impact factor: 12.969

3.  Prognosis of malignant melanoma according to regional metastases.

Authors:  U Veronesi; N Cascinelli; F Preda
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-02

4.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Authors:  W H Clark; L From; E A Bernardino; M C Mihm
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

5.  Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; P C Richards; W A Maddox
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

6.  Regional lymph node metastases and the level of invasion of primary melanoma.

Authors:  E C Holmes; W Clark; D L Morton; F R Eilber; A J Bochow
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

7.  Early metastases in regional lymph nodes and prognosis of malignant melanoma. Histological and clinical examinations in 104 lymphadenectomized patients.

Authors:  F Weidner; O P Hornstein; P Hermanek; G Wutz
Journal:  Arch Dermatol Res       Date:  1976-08-27       Impact factor: 3.017

8.  Primary melanoma thickness correlated with regional lymph node metastases.

Authors:  D F Roses; M N Harris; D Hidalgo; Q J Valensi; N Dubin
Journal:  Arch Surg       Date:  1982-07

9.  Prognostic index in malignant melanoma.

Authors:  C Schmoeckel; O Braun-Falco
Journal:  Arch Dermatol       Date:  1978-06

10.  Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness.

Authors:  A Breslow; N Cascinelli; E P van der Esch; A Morabito
Journal:  Tumori       Date:  1978-06-30
View more
  1 in total

1.  Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.

Authors:  J M Karjalainen; M J Eskelinen; S Nordling; P K Lipponen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.